Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Stock Chart & Stats
$2.21
-$0.12(-2.72%)
At close: 4:00 PM EST
$2.21
-$0.12(-2.72%)
Day’s Range― - ―
52-Week Range$2.10 - $5.81
Previous CloseN/A
Volume261.88K
Average Volume (3M)2.84M
Market Cap
$790.88M
Enterprise Value$1.02B
Total Cash (Recent Filing)$273.53M
Total Debt (Recent Filing)$545.13M
Price to Earnings (P/E)25.7
Beta0.71
Next Earnings
Feb 25, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding105,468,834
10 Day Avg. Volume4,821,930
30 Day Avg. Volume2,844,483
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)2.48
Price to Sales (P/S)2.26
P/FCF Ratio15.80
Enterprise Value/Market Cap1.29
Enterprise Value/Revenue1.27
Enterprise Value/Gross Profit1.40
Enterprise Value/Ebitda5.77
Forecast
1Y Price Target
$3.98Price Target Upside80.09% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Manufacturer Solutions GrowthManufacturer solutions segment is expanding higher-margin point-of-sale discount programs and direct-to-patient pricing models, which can improve overall margins and help drive 2026 revenue growth.
Strategic Pharmaceutical PartnershipPartnership with Novo Nordisk to offer introductory cash pricing for Ozempic and Wegovy can boost pharmacy traffic and attract new users to GoodRx services.
Telemedicine Subscription ProductLaunch of a telemedicine subscription for weight management, including virtual consultations, in-store pickup and home delivery options, creates recurring revenue streams that can stabilize revenue over time.
Bears Say
Declining Prescription VolumesDeclining prescription volumes combined with pricing pressure from pharmacy benefit manager renegotiations are eroding core prescription revenue and compressing margins.
Erosion Of Platform Data ValueFalling consumer engagement and fewer transactions weaken proprietary pricing data and pharmacy reach, reducing the platform's appeal to pharmaceutical clients and advertisers.
Pharmacy Network ReductionsMass closures of pharmacy locations have significantly reduced prescription revenues and are likely to slow the recovery of refill activity on the platform.
GoodRx Holdings News
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $2.10 and its highest was $5.81 in the past 12 months.
What is GoodRx Holdings’s market cap?
GoodRx Holdings’s market cap is $790.88M.
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Feb 25, 2026 which is in 12 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Nov 04, 2025. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.09 by -$0.01.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is 0.09.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 105,468,834 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.08 in its last earnings report, missing expectations of $0.09. Following the earnings report the stock price went up 2.147%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Currently, no hedge funds are holding shares in GDRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
GoodRx Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$3.98 (80.09% Upside)
$3.98 (80.09% Upside)
Blogger Sentiment
Bullish
GDRX Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 434.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 15.6%
Last 30 Days ▼ 15.6%
News Sentiment
Bullish
Bullish news 75%
Bearish news 25%
Bearish news 25%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.33%
12-Months-Change
Fundamentals
Return on Equity
4.90%
Trailing 12-Months
Asset Growth
-2.17%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
GDRX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a balanced view with significant growth in Manufacturer Solutions and brand partnerships, offset by declines in prescription transaction revenue due to external factors. The company is optimistic about future growth opportunities and strategic initiatives.View all GDRX earnings summariesGDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
GDRX Stock 12 Month Forecast
Average Price Target
$3.98
▲(80.09% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---